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Further Support for an Imrnunologic Basis for Psoriasis 
Jeffes a nd co ll cagucs (p. 733) report that the number of proliferat-
ing monon uclear cells in the pcriphcral blood of psoriatic paticnts 
correlates with the severity of the disease . Although it is known that 
activated proLifc rating lymphoid ce lls arc present in psoriatic skin 
I lesions, it is not known w hether thcse cells arc activated and 
proliferating bcfore they enter the les ion. It has been hypothes ized 
that s u c h ce ll s fi rst em igra te to the plaque, thcn becomc activated, 
begin to pro life ra tc, and produce cytokines in the lesion. Existing 
eviden ce suggests this hypo thesis may be in correct: it is we ll known 
that ""hile systemic low-dose cycIosporin A or methotrexate is 
effective in psori 'lsis, top ica l application of methotrexate or loca l 
injectio n of cyclosporin A is not, even w hen local concentrations 
are hig h e r than those achieved with system ic treatment. The lack of 
topica l e fFe ctiveness sugges ts that. these dru gs ma y work at distant 
sites. Because m ethotrexate works through cytotoxi c and growth-
inhibitory mechanisms, the authors rcasoned that to bc cfFective 
sys tcmi call y, the drugs l11ust inhibi t lymphoid cells already pro lif-
erating at distant sites. To test this theory, they pulse-labeled blood 
cells fi'ol11 psoriatic patients and fi'om normal volunteers. They 
found that the numbers of circulating proliferating T cells (CD3 + . 
CD4+, CD8 + ) , B cells (CD22 + ), 1110 nocytes (CD11 + ), and 
human leukocyte antigen-DR + ce lls were significantl y in creased in 
the psoriatic patients compared to contro ls. These results suggest 
that pro liferating lymphoid ce lls are present at sites distant from the 
skin and tha t sys tcmically administc rcd cytotoxic growth inhibitory 
drugs improve psoriasis through their efFects on activa ted prolifer-
ating lymphoid cells. 
Repetitive Low Doses of Ultraviolet-A Radiation Lead To Long-Term Changes in Hwnan Skin 
Lowe el al (p . 739) report that repeated low doses of ultraviolet A 
(UV A) radiation result in epidermal and de rmal photodamage, and 
that the c hanges in the dermis arc sti ll evident '12 weeks after UVA 
exposure. Both UVB and UV A components o f sunlight cause 
cuta n eO Ll S photodamage, including photoca rcinogencsis and pho-
toagin g, but the damaging effects of UVB are better doculllented. 
To b ett e r understand the role of UV A, the authors designed a 
controll e d study in whi ch measured doses of solar-simulated UV , 
suberythemal UV A, o r minimal erythemal UVA were repetitively 
delive r e d to the skin of human volunteers. T hey found that all 
rreatments produced observab le morphol ogic changes in both the 
epidern"l is and de rmis afte r only 12 wceks oftwicc-daily irradiation. 
In addition, UV A radiation produ ced greater damage than solar-
simu lated radiation , especia ll y in the de rmis, where e lastin content 
was decreased . T he authors were surprised to find that suberythe-
mal doses of UV A also dec reased e lastin con tent. T welve weeks 
afte r the UV A radiation, epidermal morpho logy had improved, but 
the dermis showed little change, suggesting that w hil e the dc rmis is 
damaged as quickly as the epidermis, thc damage may be m orC 
lasting. T hese results demonstrate that small doses of UVA radia-
tion produ ce measurable photodamage and suggest that photopro-
tection should include protection fro111 UVA, which is present 
th roughout the yea r and is poorly absorbed by chemical sunscrecns. 
Endothelin-l from Keratinocytes Induces Melanocytes to Form Dendrites 
In this is sue, Hara ('I al report (p. 744) that endothe lin-l (ET-1) 
incr eases the number and Icn gth of dendri tes pe r m elan ocyte 
(the ir "dendri c ity") as w e ll as thc percentage of dendritic 
me lanocytes. Since a single melanocyte suppli es me lanin to 
approximatel y 36 kera tinocytes, dendri c ity ofmelanocytcs prob-
abl y plays a c ru c ial ro le in pi gmcntati o n. In condi tions such as 
nevus depi gm c ntos us, in w hi ch m clanocytes dev elop stubby 
dendrites, ke ra tinocytes contain little m elan in . and skin pi gm en-
tation is co nsequentl y ligh ter. U ltravio let radi atio n , which en-
hances sk in pi gmentation , a lso pro m otes m e lano cytc dendri c ity. 
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Alth o ugh it is clea r th at m elanocytes in c rease t he ir dendri city in 
response to en viro nm e ntal signa ls su ch as laminin , co ll agen type 
I V, and so m e cytokin es and ho rm o n es , w ha t actu a ll y contro ls 
thi s d endr ic ity ;/1 /1 ; /10 is poorl y und erstoo d . Kerat inocytes seem 
to be a m aj o r so urce of th ese exogen o us signa ls. O ne such sign al 
p roduced by kcrat inocytcs, ET -1 , was fo und prev io usly by 
Im okawa and coworkers to in du cc me lan ocyte d iv isio n and to 
in c rcase m e lanin prod uctio n . M elanocytes ex press hi gh-affi ni ty 
recep to rs fo r ET - 1, and ke ra tin ocytes in crease pro du c ti o n of 
ET -1 afte r U V irradi atio n . To test the abili ty of ET - 1 to 
stimulate fo rm ati o n of dendri tcs, H ara cl al t reated cultured 
me lan ocytes w ith ET - 1 and o bserved th eir m o rph o logy. T h cy 
fo un d th at th c m clan ocytes m adc m o re and lo ngc r d cndri tes . 
THE JOU RNAL OF INVESTIGATI VE DEltMATOLOGY 
Condi tion ed m edium from U V-irrad iate d ke rat in ocytes con-
ta in ed 25 - fo ld m o rc ET -1 th an condi t ion cd m e dium from 
unirradia ted ke ratin ocyte cultures, and its enh an ce d abili ty ro 
induce m elanocyte dendri c ity was esse ntiall y e limin a ted by 
addi tio n of an t ibo dies directed aga in st ET -1. T h ese fi ndi ngs 
suggest th at UV -irradiatio n ill /1 ; /1(1 stimul ates ke ra tin ocytes to 
produ ce ET- l, w hi ch pro m otes me lan ocyte d endri city as we ll as 
in c reasin g th e numb er of m e lanocytes and the ir tyrosin ase 
activ ity, ul tim a tc ly tannin g th e skin . Undc rsta n d in g of th e 
fac to rs and m ec hanisms respo nsibl e fo r pi gm en tatio n , such as 
ET - 1 and UV , m ay eventu a ll y a ll ow the rape u tic m odul atio n of 
p ig m en tat io n . 
T oward an Animal Model for Atopic D errnatitis 
Kitagaki el al (p. 749) repo rt that rcpeated appLication of contact 
sensitizers ro the sam e skin site leads to an un expected resul t. 
Ra the r than a typical de layed hypersensitivi ty response produ ced by 
a few cncoun tc rs w ith anti gen , rcpeatcd exposures fo r 24 to 48 d 
resul ted in an immedia te- type response fo llo w ed b y a late-phase 
reactio n (LPR). C linical o bservations of patien ts w ith ato pic de r-
matitis have led to the concept that the ir skin les ions m ay resul t in 
part ITom chronic appli ca tion of allergens. Experimental studies to 
approach a possible underlying pathogenesis, however, have m ostly 
been animal studies in which experim ental contac t de rma titis w as 
induced after a few encounters with antigen , no t chroni c applica-
tion . C hroni c applicatio n has produced complex rcsul ts tha t were 
somctimes contradictory. C hronic appli ca tion of a contact sensi-
tizcr ro the sam e skin site has been sho wn to produce complete 
unresponsivcncss in that site, and it has also been repo rted that mice 
repeatedl y painted w ith contact sensitize rs prod uccd antigen-spe-
cific serum IgE. T he autho rs reconciled such discrepancies by 
assuming that repeated application of con tact sens itizers to the sam e 
skin site might lead to an immediate phase reaction accompanied by 
a loss in DTH . To test this, the au tho rs trcated Balblc mice 
chronica lly w ith trini trochl o ro benzene fo r 24 to 48 d and fo un d a 
shift, w hi ch was associated w ith epide rmal hyp erpl asia, and in -
creased number of m ast ce lls and C D4+ T cells, and later elevated 
serum levels of an tigen-specific IgE, sugges ting a shift fi·om de-
layed-type hypersensitiv ity to an immediate phase reaction fol-
lowed by a late phase respo nse. T he results provide an animal 
m odel of all e rgen- i. ,duced chronic skin inA amm ation that may be 
re levant to atopic de rmatiti s. 
Platelet-Derived Growth Factor Secreted By the Epidermis Promotes Growth and Vascularization of 
the Underlying D ermis 
Em ing el nl (p . 756) show that a gene-the rapy approach ca n be used 
to gene rate a transgenic human epidermis w hich overexpresses 
pl ate let-de ri ved growth factor A (PDG F-A) and th at when g rafted 
to athynLic mice, thi s epide rmi s stimul ates an incrca se in dermal 
conn ective tissue, fibro blasts, m ononuclea r ce lls, and bl ood vessels. 
Epiderm al keratinocytes have been shown to syn thesize and secrete 
num erous cyto kin es that act in e ithe r an au tocrin e mode, regulating 
the activ ity of the sa m e cytokinc in keratinocytcs that synthesize it, 
o r in a paracrinc mo de, in w lLich o the r ce ll s, such as those in the 
de rmis, arc the target. C ljnical evidence suggests tha t shee ts o f 
cul tured epi thelium g rafted to deep cu taneous wounds m ay pro-
m ote regeneration of the derm is; cytokines from the epithe lium 
m ay m ediate this regeneration . Altho ugh the specifi c cytokines 
involved in this p rocess arc not known , PDGF is a candida te, since 
it is secreted by ke ratinocytes, acts predominantly on de rmal ce lls, 
and is up- regul ated in tissue repa ir. To better dete rmine the role of 
PD G F in epithe lial-mesechym al in te ractions , the autno rs used 
retro virus-mediated gen e transfe r to incorpo ra te the human 
PDGF-A gene in to cultured human keratinocytcs and produced a 
300- fo ld increase in express ion o f PDGF- AA. T he m odified cells 
were then grafted on to ath ymic nude mice . Afte r seven days, the 
m odified ke ratin ocytes had formed a stratified squam ous epitlle-
lium comparable to that of unmodi fIed ce lls. T he derm al strom a 
adjacent to the PDGF-A-produ cing keratin ocytes, however, 
showed a d ram atic in crease in thickness and in the number of cells 
and bl ood vcssels, indica ting tha t PDGF-A fi·om the epithelium can 
induce signi fica n t m orpho logic changes, including increased ang io-
genesis in the de rmis (even though PDGF is no t ang iogen ic ;/I l/;tro) . 
T hese results suggest that genetically modi fied skin g rafts nLigh t be 
used to enhance wound healing. 
A N ew Monoclonal Antibody That Speciftcally R ecognizes Human T yrosinase 
Usin g a synthetic peptide , Takimoto and coll eagues (p . 764) 
have pro du ced a m o use m o noc lo n a l antibo d y that spec ifi ca ll y 
reacts with th e hum an e nzym e tyros inase and not with the 
hum an tyros in ase- re la ted protein s. Tyros inase is t he ra te-limi t-
in g en zym e in fo rm atio n o f m elanin and is fo und in m e lan ocytes 
cl ose ly assoc iated w ith prote in s ca ll ed " tyrosin ase-re lated pro-
te ins" (TRPs). To stud y the in te raction betwee n th e enzym e 
ty rosin ase and th ese protein s, and to specifi call y detect changes 
in the le ve l of tyros in ase , th e re has bee n a need fo r an antibod y 
recogni z in g ty rosina se bu t no t othe r pro tein s. Decau se of the 
hi g h ho m o logy betwee n ty rosin ase and T R.Ps, and al so becau se 
of the d ifficul ty in puri fy in g ty ros in ase w ith o ut con ta min atin g 
T RPs, prev io us a ttemp ts to pro du ce a m o noclo na l antibody to 
tyros inase yie lded an tibo di'cs tha t recogni zed both ty ros in ase and 
T RPs. To overcom e th ese pro bl em s, th e auth o rs used a synthetic 
pep tid e co ntainin g a po rti o n of hum an tyrosin ase as the im-
mun oge n . T hey sho w th at th e m o no cl o n al an tibody MAT- l 
reacts w ith cell s express in g hum an tyros in ase afte r tran sfection 
w ith hum an ty rosin ase cDN A, but not wi th ce ll s ex press ing 
human T R.P afte r transfecti on w ith hum an T R.P cD N A. M AT- 1 
w as al so show n to id enti fy epide rm al m e lanocytes in hum an skin 
secti on s. Becau se o f its ability to di stin gui sh tyros in ase from 
T RPs, thi s new antibo dy sho uld be valuabl e in studi es of th e 
co nt rol of pi gm cn tatio n . 
